Discovering interactions in polypharmacy: Impact of metamizole on the metabolism of quetiapine
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16168 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Fabian Watermeyer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital RWTH Aachen, Aachen, Germany. Hauptthemen laut MEDLINE: Quetiapine Fumarate, Drug Interactions, Dipyrone, Polypharmacy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Medikationssicherheit
Abstract (Originalsprache)
Aims
Metamizole is quite an old drug with analgesic, antipyretic and spasmolytic properties. Recent findings have shown that it may induce several cytochrome P450 (CYP) enzymes, especially CYP3A4 and CYP2B6. The clinical relevance of these properties is uncertain. We aimed to unravel potential pharmacokinetic interactions between metamizole and the CYP3A4 substrate quetiapine.
Methods
Plasma concentrations of quetiapine from a large therapeutic drug monitoring database were analysed. Two groups of 33 patients, either receiving quetiapine as a monotherapy (without CYP modulating comedications) or with concomitantly applied metamizole, were compared addressing a potential impact of metamizole on the metabolism of quetiapine being reflected in differences of plasma concentrations of quetiapine and dose‐adjusted plasma concentrations.
Results
Patients comedicated with metamizole showed >50% lower plasma concentrations of quetiapine (median 45.2 ng/mL, Q 1 = 15.5; Q 3 = 90.5 vs . 92.0 ng/mL, Q 1 = 52.3; Q 3 = 203.8, P = .003). The dose‐adjusted plasma concentrations were 69% lower in the comedication group ( P = .001). Subgroup analyses did not suggest a dose dependency of the metamizole effect or an influence of quetiapine formulation (immediate vs . extended release). Finally, the comedication group exhibited a significantly higher proportion of patients whose quetiapine concentrations were below the therapeutic reference range (78.8% in the metamizole group vs . 54.4% in the control group, P = .037) indicating therapeutically insufficient drug concentrations.
Conclusion
The combination of metamizole and quetiapine leads to significantly lower drug concentrations of quetiapine, probably via an induction of CYP3A4. Clinicians must consider the risk of adverse drug reactions, especially treatment failure under quetiapine when adding metamizole.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital RWTH Aachen, Aachen, Germany.
- JARA-Translational Brain Medicine, RWTH Aachen University, Aachen, Germany.
- Institute of Physiology, University Hospital RWTH Aachen, Aachen, Germany.
- Department of Psychiatry and Psychotherapy, Clinical Pharmacology, University of Regensburg, Regensburg, Germany.
- Department of Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany.
- Clinical Pharmacology Institute AGATE gGmbH, Pentling, Germany.
ORCID-Profile: Arnim Johannes Gaebler, Michael Paulzen
Zitieren
APA
Watermeyer, F., Gaebler, A. J., Neuner, I., Haen, E., Hiemke, C., Schoretsanitis, G., & Paulzen, M. (2024). Discovering interactions in polypharmacy: Impact of metamizole on the metabolism of quetiapine. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16168
Vancouver
Watermeyer F, Gaebler AJ, Neuner I, Haen E, Hiemke C, Schoretsanitis G, et al. Discovering interactions in polypharmacy: Impact of metamizole on the metabolism of quetiapine. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16168
BibTeX
@article{Watermeyer2024,
author = {Watermeyer, Fabian and Gaebler, Arnim Johannes and Neuner, Irene and Haen, Ekkehard and Hiemke, Christoph and Schoretsanitis, Georgios and Paulzen, Michael},
title = {Discovering interactions in polypharmacy: Impact of metamizole on the metabolism of quetiapine},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16168}
}
EUVIMED